Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts.
about
Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve MarkersCan anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progressRole of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a reviewIs AMH a regulator of follicular atresia?Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implicationsThe ageing ovary and uterus: new biological insightsAMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysisThe impact of depot GnRH agonist on AMH levels in healthy reproductive-aged womenPrognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocolDiscordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.In vivo fate mapping of cryopreserved murine ovarian grafts.Low-cost in vitro fertilization: current insights.The physiology and clinical utility of anti-Mullerian hormone in women.Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patientsPrediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking statusRole of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis.Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors.Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review.Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.Serum antimüllerian hormone in healthy premenopausal women.Menstrual cycle length: a surrogate measure of reproductive health capable of improving the accuracy of biochemical/sonographical ovarian reserve test in estimating the reproductive chances of women referred to ART.Genetic variants and environmental factors associated with hormonal markers of ovarian reserve in Caucasian and African American womenWhat is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?Growth Hormone Ameliorates the Radiotherapy-Induced Ovarian Follicular Loss in Rats: Impact on Oxidative Stress, Apoptosis and IGF-1/IGF-1R Axis.Does AMH Reflect Follicle Number Similarly in Women with and without PCOS?The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments.Use of anti-mullerian hormone for testing ovarian reserve: a survey of 796 infertility clinics worldwideA new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulationComparison of anti-mullerian hormone and antral follicle count for assessment of ovarian reserve.Anti-Mullerian-hormone levels during pregnancy and postpartumEffect of salpingectomy, ovarian cystectomy and unilateral salpingo-oopherectomy on ovarian reserve.How Much Does AMH Really Vary in Normal Women?Involvement of mesosalpinx in endometrioma is a possible risk factor for decrease of ovarian reserve after cystectomy: a retrospective cohort study.Prediction of metaphase II oocytes according to different serum Anti-Müllerian hormone (AMH) levels in antagonist ICSI cycles.Short Term Culture of Vitrified Human Ovarian Cortical Tissue to Assess the Cryopreservation Outcome: Molecular and Morphological Analysis.Fertility preservation in girls and young women.Prevention of ovarian damage and infertility in young female cancer patients awaiting chemotherapy--clinical approach and unsolved issues.Ovarian antral folliculogenesis during the human menstrual cycle: a review.Biomarkers of ovarian reserve.Anti-Müllerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review.
P2860
Q26765770-D2FF93C4-52FD-4FED-AEAC-3ED96A06140EQ26773554-AAFEEA78-8845-43C9-9844-1B78126105A5Q26774060-E37263B9-5342-43C5-8607-305A878AF19AQ27006736-397ABF0F-9E8D-41F0-89D2-0E4B90DA67B9Q28239980-12A8FD8B-18BD-40DE-BBA1-6F1A93C6CABCQ28278102-06D564C8-A1A3-493A-87EF-0790D2BA6D97Q28289118-29BC5628-83C9-4DD4-93CC-0D52FB12F6E1Q28392230-1A17FC29-4419-48B0-8B8D-11E60AA021ADQ33888265-DD744213-4543-4A4C-AD1C-6AB0A865D5DBQ33952002-806766B9-31B4-449F-A7F3-9775D5858A67Q34091382-8205D3D8-B9B9-46E4-9422-3759FAF928B2Q34110154-D91C73AA-AD48-47F2-890A-B6D1B3E6AF57Q34398233-C6ADF768-3A0E-4261-B925-A5FCCF88CE23Q34550633-5FBFF065-82C7-4EFB-A9CA-A9DEFD71B925Q34625478-77399301-98AD-4B9B-B42C-54A6AB451328Q34700094-F0C42D50-3D54-406D-959E-A06F104D65AFQ34709073-7D0E6840-93D1-4953-9F4B-96B8EDADB37EQ34761841-CB73EF64-5736-4268-907E-EC5FEB04CACDQ35147438-17E004BE-2031-4694-8833-2531A94CF982Q35185385-3E1BF930-5AE8-460E-B251-DFEB983CE63FQ35404298-37295886-3058-4898-9997-7ABD79915D8FQ35671932-53E34EDF-A839-4CB8-8D7F-9E7345A472FEQ35750252-CE4A472A-1A3E-4DD1-AAE8-D87BD2D0D0A5Q35806248-F7B2E999-311A-4FBE-B468-BDB1B1E632DEQ35901133-C1A5D767-3619-4722-ACA6-B47EB2D56450Q35976287-A5F0F1E2-CCC9-4875-B010-7514A6E3B407Q36192080-96330321-1A93-41CC-A1F1-25E67208DF3AQ36594368-6F023ECA-8AC3-40A7-894B-016BCD39111EQ36706499-B4ACDF0C-6EF9-4964-8596-7C44E4BAE3F4Q37048647-B3BBEF60-D71F-4044-B3C9-4847D74C9877Q37104631-4CA5D703-778A-4A13-AB02-B3319F9EC9BBQ37367598-C8320CA7-64C1-4BBA-88B7-EA72EE59F0E2Q37374594-0457D9CB-D517-4DE0-AD44-FBC4BE31BA22Q37605344-8F7152AA-DFD8-45D4-9E4C-4A7EC00F7737Q37713358-AA139598-C3EA-41CE-809F-79EA4E3A3431Q37875896-5501AD63-0AA4-4F15-954A-69AF864467D5Q37938748-6301C534-B84A-46EB-94C4-45A267CCF8A2Q37954146-C0C32841-0A6A-44DA-931D-BD750F0FCFDBQ38079621-90ADF5ED-CE7A-49AE-B1AC-099E4B65883FQ38250303-E763CA0C-B9CD-4EDE-90DE-E2FC6891A245
P2860
Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Comparison of inter- and intra ...... ne and antral follicle counts.
@en
Comparison of inter- and intra ...... ne and antral follicle counts.
@nl
type
label
Comparison of inter- and intra ...... ne and antral follicle counts.
@en
Comparison of inter- and intra ...... ne and antral follicle counts.
@nl
prefLabel
Comparison of inter- and intra ...... ne and antral follicle counts.
@en
Comparison of inter- and intra ...... ne and antral follicle counts.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of inter- and intra ...... ne and antral follicle counts.
@en
P2093
B C Fauser
C B Lambalk
C W N Looman
F J Broekmans
J van Disseldorp
M J C Eijkemans
P2860
P304
P356
10.1093/HUMREP/DEP366
P407
P577
2009-10-19T00:00:00Z